openPR Logo
Press release

Non-Small Cell Lung Cancer Therapeutics Market: Rapid approvals for drugs for non-small cell lung cancer by regulatory bodies and generous monetary assistance for research has also filliped the market

01-16-2017 09:37 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Non-Small Cell Lung Cancer Therapeutics Market: Rapid

In this research report, the global NSCLC therapeutics market has been studied with a microscopic view. It aims at presenting a detailed market assessment on the basis of its past as well as current performance. The latest trends and growth opportunities within this market have been examined in-depth to determine its future status in this study.

The global market for non-small cell lung cancer therapeutics has been witnessing robust growth, thanks to the new product launches in the recent years. The key players in the market are emphasizing on developing a strong pipeline of drugs to stay afloat in a highly competitive environment and gain higher shares in the revenue pie.

Non-small cell lung cancer has a high probability of metastasizing into bones and several tissues of the body, making it extremely challenging to detect and treat. Several drugs that are used in the therapeutics of non-small cell lung cancer range from regular treatments to targeted therapeutics, thus generating potential growth opportunities for the key players in the market. In this blog, Transparency Market Research provides solutions to some of the crucial questions related to the non-small cell lung cancer therapeutics market, focusing on the current trends and opportunities in the market.

Read Full Report: http://www.transparencymarketresearch.com/non-small-cell-lung-cancer-market.html

What are the primary factors that are influencing the demand for non-small cell lung cancer therapeutics market across the globe?

The expanding pool of patients and the growing awareness regarding the availability of therapeutics are the key factors fueling the growth of the global non-small cell lung cancer therapeutics market. In addition, rising active and passive smoking activities, unhealthy lifestyle, and increasing geriatric population are some of the other factors expected to augment the growth of the market in the next few years.

The growing prevalence of diseases around the world and several initiatives taken by public and private organizations are further estimated to encourage the growth of the non-small cell lung cancer therapeutics market across the globe. Due to these growth prospects, the global market for non-small cell lung cancer therapeutics is estimated to rise from US$4.9 bn in 2014 to US$15.1 bn by the end of 2023, exhibiting a 12.10% CAGR between 2015 and 2023.

How have the market players contributed towards the expansion of the global non-small cell lung cancer therapeutics market?

Eli Lilly and Company, AstraZeneca plc, Celgene Corporation, Boehringer Ingelheim, Genentech, Inc., Pfizer, Inc., Novartis AG, and Bristol-Myers Squibb are some of the leading players operating in the non-small cell lung cancer therapeutics market across the globe. These players are competing with each other to develop new drugs at an affordable price to effectively treat and cure non-small cell lung cancer.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=504

In addition, the ongoing research for immune checkpoint inhibitors and combination therapy for non-small cell lung cancer is expected to generate potential opportunities for the market players in the near future. Key licensing and co-development deals taking place within the leading players are projected to develop innovative therapeutics in the near future, thus propelling the overall market.

What are the recent developments influencing the market revenues of the global non-small cell lung cancer therapeutics market?

The global non-small cell lung cancer therapeutics market has been facing a significant issue concerning the resistance to targeted therapies, such as Tarceva or Xalkori. The introduction of new drugs in the final development stage, such as Avelumab, MPDL3280A, MEDI4736, and Abemaciclib are expected to gain the status of novel drugs in the near future. These drugs are primarily based on simple chemistries to advanced complex protein. Moreover, the drugs for non-small cell lung cancer are acquiring swift approvals by the regulatory bodies and grants for research. This is projected to encourage emergence of new generation of drugs in the global market.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Small Cell Lung Cancer Therapeutics Market: Rapid approvals for drugs for non-small cell lung cancer by regulatory bodies and generous monetary assistance for research has also filliped the market here

News-ID: 413250 • Views:

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for Transparency

transparency market research
The global Custom Antibody Market market is estimated to attain a valuation of US$1 Billion by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.085% during the forecast period, 2023 to 2033. The key objective of the TMR report is to offer a complete assessment of the global market including major leading
Transparency Market Research
A belt drive is a type of power transmission device which is a looped belt wound around a pair of pulley so as to transmit power between two or more rotating shafts. Compared to other power transmitting devices, belt drives are more preferred in mechanical industry due to easy installation, numerous speed ratio selections, less power loss and comparative low price. Belt drive protects the rotating machinery from overload fluctuations
Transparency Market Research
An ultrasonic motor is an electric motor which is driven by the ultrasonic vibration of a component. The stator of the motor is supported by piezoelectric components in ultrasonic frequency range which produces different types of vibrations depending on its arrangement. In other words, ultrasonic motor is a type of electric motor that transforms ultrasonic physical vibrations to linear motion, produced by a piezo-transducer. Ultrasonic motors therefore do not use
More transparency in Engineering IT
CPO certification helps evaluate openness of IT systems Digitalization is making openness in the linking of IT solutions increasingly important. The Code of PLM Openness (CPO), developed by the ProSTEP iViP Association, supplies a concrete approach for achieving precisely that. Fraunhofer IAO has now developed an effective certification for companies, which helps them comply with the CPO criteria. Industrie 4.0 requires intensified collaboration between various tools and systems. Only when
eDataCenterAnalyzer Increases Transparency in Data Centers
30 June 2016. Walldorf, Germany. – fluid Operations™ AG (fluidOps), a leader in semantic technologies, today launched eDataCenterAnalyzer™, an app that increases transparency in data centers. With the launch of this app and new releases of its Smart Data Platform Information Workbench™ and cloud management app eCloudManager™, the company has set the cornerstone for the future development of its product portfolio. eDataCenterAnalyzer combines the full functionality of Information Workbench with innovative
Transparency across the entire process chain
Leitner Spedition implements best4log-x • Austrian trucking company uses arvato Systems solution • End-to-end process management provides higher efficiency (arvato Systems) Gütersloh / Unterpremstätten – Since the beginning of 2015, the Austrian trucking company Leitner Spedition has been working with the best4log-x transport management system. This SAP-based solution from arvato Systems provides an integrated digital information flow and supports mid-sized companies in achieving a transparent process design. Controlling and Reporting have seen a